Analysis of hematopoietic stem cell transplant engraftment: Use of loss or gain of microsatellite alleles to identify residual hematopoietic malignancy

Diagnostic Molecular Pathology

Volumn 20, Issue 4, 2011, Pages 194-202

  Lin, Ming Tseh ^a   Tseng, Li Hui ^a,b   Beierl, Katie ^a   Harada, Shuko ^a   Hafez, Michael J ^a   Eshleman, James R ^a,c   Gocke, Christopher D ^a,c  

^a Park SB202 ^*  (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

allogeneic hematopoietic stem cell transplantation; chimerism; leukemia relapse; microsatellite; Short tandem repeat

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLELE; ARTICLE; BLOOD; BONE MARROW; CANCER CELL; CANCER CHEMOTHERAPY; CANCER PATIENT; CASE REPORT; CHEMORADIOTHERAPY; CHILD; CHIMERA; CHROMOSOME; COPY NUMBER VARIATION; ENGRAFTMENT; FEMALE; GENE LOCUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LARGE CELL LYMPHOMA; MALE; MONOSOMY 7; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; SHORT TANDEM REPEAT; T CELL LYMPHOMA; TUMOR BIOPSY;

ADULT; AGED; ALLELES; CHILD, PRESCHOOL; DNA, NEOPLASM; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; LYMPHOMA; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM, RESIDUAL;

EID: 81855180897     PISSN: 10529551     EISSN: 15334066     Source Type: Journal    
DOI: 10.1097/PDM.0b013e31821dac16     Document Type: Article

References (19)

1. Thiede C, Florek M, Bornhauser M, et al. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant. 1999;23:1055-1060. (Pubitemid 29250852)
2. Nuckols JD, Rasheed BK, McGlennen RC, et al. Evaluation of an automated technique for assessment of marrow engraftment after allogeneic bone marrow transplantation using a commercially available kit. Am J Clin Pathol. 2000;113:135-140. (Pubitemid 30217349)
3. Antin JH, Childs R, FilipovichAH, et al. Establishment ofcomplete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. BiolBloodMarrow Transplant. 2001;7:473-485. (Pubitemid 32976266)
4. Khan F, Agarwal A, Agrawal S. Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme. Bone Marrow Transplant. 2004;34:1-12. (Pubitemid 39022951)
5. Bader P, Holle W, Klingebiel T, et al. Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children. Bone Marrow Transplant. 1997;19:697-702. (Pubitemid 27182493)
6. Roman J, Martin C, Torres A, et al. Importance ofmixed chimerism to predict relapse in persistently BCR/ABL positive long survivors after allogeneic bone marrow transplantation for chronic myeloid leukemia. Leuk Lymphoma. 1998;28:541-550. (Pubitemid 28203904)
7. van Leeuwen JE, van Tol MJ, Joosten AM, et al. Persistence of host-type hematopoiesis after allogeneic bone marrow transplanta-tion for leukemia is significantly related to the recipient's age and/or the conditioning regimen, but it is not associated with an increased risk ofrelapse. Blood. 1994;83:3059-3067.
8. Molloy K, Goulden N, Lawler M, et al. Patterns ofhematopoietic chimerism following bone marrow transplantation for childhood acute lymphoblastic leukemia from volunteer unrelated donors. Blood. 1996;87:3027-3031. (Pubitemid 26102256)
9. Thiede C, Bornhauser M, Ehninger G. Strategies and clinical implications of chimerism diagnostics after allogeneic hematopoietic stem cell transplantation. Acta Haematol. 2004;112:16-23. (Pubitemid 38716245)
10. Childs R, Clave E, Contentin N, et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplanta-tion: full donor T-cell chimerism precedes alloimmune responses. Blood. 1999;94:3234-3241. (Pubitemid 29512733)
11. Zhou M, Sheldon S, Akel N, et al. Chromosomal aneuploidy in leukemic blast crisis: a potential source of error in interpretation of bone marrow engraftment analysis by VNTR amplification. Mol Diagn. 1999;4:153-157. (Pubitemid 29326134)
12. Schichman SA, Suess P, Vertino AM, et al. Comparison of short tandem repeat and variable number tandem repeat genetic markers for quantitative determination ofallogeneic bone marrow transplant engraftment. Bone Marrow Transplant. 2002;29:243-248. (Pubitemid 34189517)
13. Swierczynski SL, Hafez MJ, Philips J, et al. Bone marrow engraftment analysis after granulocyte transfusion. J Mol Diagn. 2005;7:422-426. (Pubitemid 41149658)
14. Lin MT, Rich RG, Shipley RF, et al. A molecular fraction collecting tool for the ABI 310 automated sequencer. J Mol Diagn. 2007;9: 598-603. (Pubitemid 350158418)
15. Wang CC, Tien HF, Lin MT, et al. Consistent presence of isochromosome 7q in hepatosplenic T gamma/delta lymphoma: a new cytogenetic-clinicopathologic entity. Genes Chromosomes Can-cer. 1995;12:161-164.
16. Jotterand M, Parlier V. Diagnostic and prognostic significance of cytogenetics in adult primary myelodysplastic syndromes. Leuk Lymphoma. 1996;23:253-266. (Pubitemid 27029338)
17. Mauritzson N, Albin M, Rylander L, et al. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001. Leuke-mia. 2002;16:2366-2378. (Pubitemid 36067289)
18. Preiss BS, Bergman OJ, Friis LS, et al. AML Study Group of Southern Denmark: cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML. Cancer Genet Cytogenet. 2010;202:108-122.
19. Silzle E, Shane RM, Rich RG, et al. Reference intervals for microsatellite loss of heterozygosity (LOH) in brain tumor biopsies. J Mol Diagn. 2008;10:613a.